Markets are at record highs. Valuations appear to be stretched. Here is the latest on valuations from some of the best asset managers, market commentators, financial analysts and CMT's of today:
Valuations
Aptevo Therapeutics Touts Data From Investigational Drug Trial For
Aggressive Blood Cancer
-
Aptevo stock spikes as new AML trial data show 85% remission rate with
mipletamig triplet therapy, supported by strong safety and no CRS observed.
read m...
46 minutes ago